1. Home
  2. SGA vs SRTS Comparison

SGA vs SRTS Comparison

Compare SGA & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Saga Communications Inc. (FL)

SGA

Saga Communications Inc. (FL)

N/A

Current Price

$8.63

Market Cap

56.6M

ML Signal

N/A

Logo Sensus Healthcare Inc.

SRTS

Sensus Healthcare Inc.

HOLD

Current Price

$2.96

Market Cap

48.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGA
SRTS
Founded
1986
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.6M
48.9M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
SGA
SRTS
Price
$8.63
$2.96
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $7.00
AVG Volume (30 Days)
13.1K
★ 33.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
★ 9.05%
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $124,829,000.00
$27,482,000.00
Revenue This Year
$6.74
$2.00
Revenue Next Year
N/A
$34.23
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 5.65
N/A
52 Week Low
$8.24
$2.66
52 Week High
$13.05
$5.49

Technical Indicators

Market Signals
Indicator
SGA
SRTS
Relative Strength Index (RSI) 41.89 41.10
Support Level $8.61 $2.97
Resistance Level $9.41 $3.30
Average True Range (ATR) 0.21 0.10
MACD -0.03 -0.03
Stochastic Oscillator 17.80 13.22

Price Performance

Historical Comparison
SGA
SRTS

About SGA Saga Communications Inc. (FL)

Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: